Generation and characterization of two human induced pluripotent stem cell lines from myotonic dystrophy type 1
Pooja Darji1, Wenqiang Liu2, Wenshu Zeng2
1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; California State University Channel Islands, Camarillo, CA 93012, USA.
Abstract:
The neuromuscular disorder myotonic dystrophy Type 1 (DM1) is brought on by CTG trinucleotide repeat expansions in the dystrophia myotonica-protein kinase (DMPK) gene, which leads to progressive myotonia and muscle weakness. We used Sendai virus reprogramming to generate two induced pluripotent stem cell (iPSC) lines (SCVIi134-A and SCVIi137-A) from peripheral blood mononuclear cells (PBMCs) of female DM1 patients carrying CTG repeat expansion. Both lines have normal karyotypes, show expression of undifferentiated human iPSC state markers, and differentiate into all three germ layers. These iPSC lines provide a platform for studying RNA toxicity at the molecular level and for drug development.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Induced Pluripotent Stem Cells
Somatic...
EPS and iPS Cells in Disease Research


